应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NKTX Nkarta
盘前交易 12-20 06:55:32 EST
2.20
+0.03
+1.38%
最高
2.23
最低
2.08
成交量
257.25万
今开
2.18
昨收
2.17
日振幅
6.91%
总市值
1.55亿
流通市值
9,655万
总股本
7,057万
成交额
551.77万
换手率
5.86%
流通股本
4,389万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Nkarta, Inc.盘中异动 早盘股价大涨5.29%报2.39美元
市场透视 · 12-18 22:43
Nkarta, Inc.盘中异动 早盘股价大涨5.29%报2.39美元
Nkarta, Inc.盘中异动 下午盘股价大涨5.46%
市场透视 · 12-14
Nkarta, Inc.盘中异动 下午盘股价大涨5.46%
Nkarta, Inc.盘中异动 早盘股价大跌5.56%
市场透视 · 12-13
Nkarta, Inc.盘中异动 早盘股价大跌5.56%
Nkarta, Inc.盘中异动 急速上涨5.26%
市场透视 · 12-11
Nkarta, Inc.盘中异动 急速上涨5.26%
Nkarta, Inc.盘中异动 早盘大幅跳水5.51%
市场透视 · 12-05
Nkarta, Inc.盘中异动 早盘大幅跳水5.51%
Nkarta, Inc.盘中异动 大幅上涨5.19%
市场透视 · 12-05
Nkarta, Inc.盘中异动 大幅上涨5.19%
Nkarta, Inc.盘中异动 急速跳水5.61%报2.86美元
市场透视 · 12-03
Nkarta, Inc.盘中异动 急速跳水5.61%报2.86美元
Nkarta, Inc.盘中异动 下午盘股价大涨5.05%
市场透视 · 12-03
Nkarta, Inc.盘中异动 下午盘股价大涨5.05%
Nkarta, Inc.盘中异动 早盘急速下挫5.52%报2.83美元
市场透视 · 11-29
Nkarta, Inc.盘中异动 早盘急速下挫5.52%报2.83美元
Nkarta, Inc.盘中异动 早盘急速拉升6.13%
市场透视 · 11-27
Nkarta, Inc.盘中异动 早盘急速拉升6.13%
Nkarta, Inc.盘中异动 早盘股价大涨5.31%报2.58美元
市场透视 · 11-25
Nkarta, Inc.盘中异动 早盘股价大涨5.31%报2.58美元
Nkarta, Inc.盘中异动 股价大跌5.33%报2.76美元
市场透视 · 11-15
Nkarta, Inc.盘中异动 股价大跌5.33%报2.76美元
Nkarta, Inc.2024财年第三财季实现净利润-28.34百万美元,同比减少10.49%
市场透视 · 11-14
Nkarta, Inc.2024财年第三财季实现净利润-28.34百万美元,同比减少10.49%
Nkarta, Inc.盘中异动 股价大涨5.02%
市场透视 · 11-11
Nkarta, Inc.盘中异动 股价大涨5.02%
Nkarta, Inc.盘中异动 早盘快速跳水5.06%报3.10美元
市场透视 · 11-08
Nkarta, Inc.盘中异动 早盘快速跳水5.06%报3.10美元
Nkarta, Inc.盘中异动 下午盘急速下跌5.07%报3.18美元
市场透视 · 11-08
Nkarta, Inc.盘中异动 下午盘急速下跌5.07%报3.18美元
Nkarta Inc 预计每股亏损 36 美分 - 财报前瞻
Reuters · 11-06
Nkarta Inc 预计每股亏损 36 美分 - 财报前瞻
Nkarta, Inc.盘中异动 早盘快速上涨5.02%报3.35美元
市场透视 · 11-04
Nkarta, Inc.盘中异动 早盘快速上涨5.02%报3.35美元
Nkarta, Inc.盘中异动 早盘股价大涨5.19%报3.24美元
市场透视 · 11-01
Nkarta, Inc.盘中异动 早盘股价大涨5.19%报3.24美元
Nkarta, Inc.盘中异动 急速下挫5.07%
市场透视 · 10-31
Nkarta, Inc.盘中异动 急速下挫5.07%
加载更多
公司概况
公司名称:
Nkarta
所属市场:
NASDAQ
上市日期:
--
主营业务:
Nkarta, Inc.于2015年7月在特拉华州成立。该公司是一家私人生物制药公司,致力于开发工程化的自然杀伤(NK)细胞来对抗癌症。该公司致力于利用NK细胞的天然强大功能来识别和杀死异常细胞,并募集适应性免疫效应子以产生特异性和持久性的反应。
发行价格:
--
{"stockData":{"symbol":"NKTX","market":"US","secType":"STK","nameCN":"Nkarta","latestPrice":2.2,"timestamp":1734642000000,"preClose":2.17,"halted":0,"volume":2572482,"delay":0,"floatShares":43886072,"shares":70568754,"eps":-1.791781,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.03,"latestTime":"12-20 06:55:32 EST","open":2.18,"high":2.23,"low":2.08,"amount":5517695.290199,"amplitude":0.069124,"askPrice":2.38,"askSize":100,"bidPrice":2,"bidSize":8,"shortable":3,"etf":0,"ttmEps":-1.791781,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734705000000},"adr":0,"listingDate":1594353600000,"adjPreClose":2.2,"postHourTrading":{"tag":"盘后","latestPrice":2.19,"preClose":2.2,"latestTime":"19:48 EST","volume":8737,"amount":19187.05,"timestamp":1734655693407},"volumeRatio":1.1647912065692705,"impliedVol":1.5897,"impliedVolPercentile":0.8088},"requestUrl":"/m/hq/s/NKTX","defaultTab":"news","newsList":[{"id":"2492800791","title":"Nkarta, Inc.盘中异动 早盘股价大涨5.29%报2.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492800791","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492800791?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:43","pubTimestamp":1734533024,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日22时43分,Nkarta, Inc.股票出现异动,股价大幅上涨5.29%。截至发稿,该股报2.39美元/股,成交量16.0821万股,换手率0.23%,振幅5.29%。Nkarta, Inc.股票所在的生物技术行业中,整体跌幅为0.10%。Nkarta, Inc.公司简介:Nkarta Inc 是一家生物制药公司,致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218224344984cb2c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218224344984cb2c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NKTX","BK4505"],"gpt_icon":0},{"id":"2491309127","title":"Nkarta, Inc.盘中异动 下午盘股价大涨5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491309127","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491309127?lang=zh_cn&edition=full","pubTime":"2024-12-14 02:14","pubTimestamp":1734113688,"startTime":"0","endTime":"0","summary":"北京时间2024年12月14日02时14分,Nkarta, Inc.股票出现波动,股价快速上涨5.46%。截至发稿,该股报2.42美元/股,成交量163.532万股,换手率2.32%,振幅6.99%。Nkarta, Inc.股票所在的生物技术行业中,整体跌幅为0.57%。Nkarta, Inc.公司简介:Nkarta Inc 是一家生物制药公司,致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214021448ab75eea5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214021448ab75eea5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","NKTX","BK4139"],"gpt_icon":0},{"id":"2491336527","title":"Nkarta, Inc.盘中异动 早盘股价大跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491336527","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491336527?lang=zh_cn&edition=full","pubTime":"2024-12-13 00:23","pubTimestamp":1734020624,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日00时23分,Nkarta, Inc.股票出现波动,股价快速下跌5.56%。Nkarta, Inc.股票所在的生物技术行业中,整体跌幅为0.99%。其相关个股中,Tc Biopharm Plc C/Wts 10/02/2028 、Palisade Bio, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc.较为活跃,换手率分别为3472.19%、884.12%、77.53%,振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Cardio Diagnostics Holdings Inc C/Wts To Pur Com,振幅分别为115.92%、86.92%、80.04%。Nkarta, Inc.公司简介:Nkarta Inc 是一家生物制药公司,致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213002344984b9b40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213002344984b9b40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4505","BK4139"],"gpt_icon":0},{"id":"2490417690","title":"Nkarta, Inc.盘中异动 急速上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490417690","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490417690?lang=zh_cn&edition=full","pubTime":"2024-12-11 01:52","pubTimestamp":1733853131,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日01时52分,Nkarta, Inc.股票出现异动,股价急速上涨5.26%。Nkarta, Inc.股票所在的生物技术行业中,整体跌幅为0.80%。其相关个股中,Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Uniqure N.V.涨幅较大,Psyence Biomedical Ltd.、Processa Pharmaceuticals, Inc.、Chimerix, Inc.较为活跃,换手率分别为1971.90%、470.20%、170.13%,振幅较大的相关个股有Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Jupiter Neurosciences, Inc.,振幅分别为154.91%、131.78%、121.49%。Nkarta, Inc.公司简介:Nkarta Inc 是一家生物制药公司,致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121101521195e8b7f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121101521195e8b7f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","NKTX"],"gpt_icon":0},{"id":"2489468143","title":"Nkarta, Inc.盘中异动 早盘大幅跳水5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489468143","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489468143?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:45","pubTimestamp":1733409934,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日22时45分,Nkarta, Inc.股票出现波动,股价快速下挫5.51%。Nkarta, Inc.股票所在的生物技术行业中,整体涨幅为0.02%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大,Psyence Biomedical Ltd.、Silexion Therapeutics Corp、Molecular Templates, Inc.较为活跃,换手率分别为2049.54%、209.61%、75.40%,振幅较大的相关个股有Psyence Biomedical Ltd.、Aprea Therapeutics, Inc.、Molecular Templates, Inc.,振幅分别为29.76%、20.90%、19.51%。Nkarta, Inc.公司简介:Nkarta Inc 是一家生物制药公司,致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205224534971be226&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205224534971be226&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","NKTX"],"gpt_icon":0},{"id":"2489149081","title":"Nkarta, Inc.盘中异动 大幅上涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489149081","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489149081?lang=zh_cn&edition=full","pubTime":"2024-12-05 01:03","pubTimestamp":1733331787,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日01时03分,Nkarta, Inc.股票出现异动,股价快速拉升5.19%。Nkarta, Inc.股票所在的生物技术行业中,整体涨幅为0.54%。其相关个股中,Cyclerion Therapeutics, Inc.、Exicure, Inc.、Heron Therapeutics, Inc.涨幅较大,Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃,换手率分别为3332.60%、256.88%、131.16%,振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Apollomics Inc C/Wts 01/04/2028 、Eterna Therapeutics Inc.,振幅分别为237.89%、61.31%、55.22%。Nkarta, Inc.公司简介:Nkarta Inc 是一家生物制药公司,致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205010307971ba778&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205010307971ba778&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4139","BK4505"],"gpt_icon":0},{"id":"2488794656","title":"Nkarta, Inc.盘中异动 急速跳水5.61%报2.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488794656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488794656?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:46","pubTimestamp":1733237175,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时46分,Nkarta, Inc.股票出现波动,股价大幅跳水5.61%。截至发稿,该股报2.86美元/股,成交量10.1485万股,换手率0.14%,振幅9.09%。Nkarta, Inc.股票所在的生物技术行业中,整体跌幅为0.40%。Nkarta, Inc.公司简介:Nkarta Inc 是一家生物制药公司,致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203224615a2699da6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203224615a2699da6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","NKTX","BK4139"],"gpt_icon":0},{"id":"2488047646","title":"Nkarta, Inc.盘中异动 下午盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488047646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488047646?lang=zh_cn&edition=full","pubTime":"2024-12-03 02:11","pubTimestamp":1733163100,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日02时11分,Nkarta, Inc.股票出现波动,股价大幅拉升5.05%。Nkarta, Inc.股票所在的生物技术行业中,整体跌幅为0.08%。其相关个股中,Senti Biosciences, Inc.、Purple Biotech Ltd、Cingulate Inc C/Wts 10/12/2026 涨幅较大,Purple Biotech Ltd、Senti Biosciences, Inc.、Quoin Pharmaceuticals Ltd较为活跃,换手率分别为2533.89%、2393.89%、641.39%,振幅较大的相关个股有Senti Biosciences, Inc.、Purple Biotech Ltd、Quoin Pharmaceuticals Ltd,振幅分别为481.02%、289.12%、131.67%。Nkarta, Inc.公司简介:Nkarta Inc 是一家生物制药公司,致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203021140abf068d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203021140abf068d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","NKTX","BK4139"],"gpt_icon":0},{"id":"2487856659","title":"Nkarta, Inc.盘中异动 早盘急速下挫5.52%报2.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2487856659","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487856659?lang=zh_cn&edition=full","pubTime":"2024-11-29 23:37","pubTimestamp":1732894670,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日23时37分,Nkarta, Inc.股票出现波动,股价急速跳水5.52%。截至发稿,该股报2.83美元/股,成交量73.1365万股,换手率1.04%,振幅4.68%。Nkarta, Inc.股票所在的生物技术行业中,整体涨幅为0.02%。Nkarta, Inc.公司简介:Nkarta Inc 是一家生物制药公司,致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112923375098e46922&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112923375098e46922&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NKTX","BK4505"],"gpt_icon":0},{"id":"2486878228","title":"Nkarta, Inc.盘中异动 早盘急速拉升6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486878228","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486878228?lang=zh_cn&edition=full","pubTime":"2024-11-27 22:33","pubTimestamp":1732717984,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日22时33分,Nkarta, Inc.股票出现异动,股价大幅拉升6.13%。Nkarta, Inc.股票所在的生物技术行业中,整体涨幅为0.31%。其相关个股中,Cyclerion Therapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 、Tuhura Biosciences, Inc.涨幅较大,Cyclerion Therapeutics, Inc.、Outlook Therapeutics, Inc.、Molecular Templates, Inc.较为活跃,换手率分别为797.31%、27.20%、6.90%,振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Cyclerion Therapeutics, Inc.、Tuhura Biosciences, Inc.,振幅分别为19.11%、13.97%、11.32%。Nkarta, Inc.公司简介:Nkarta Inc 是一家生物制药公司,致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112722330498e44ea1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112722330498e44ea1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4139","BK4505"],"gpt_icon":0},{"id":"2486103856","title":"Nkarta, Inc.盘中异动 早盘股价大涨5.31%报2.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486103856","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486103856?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:32","pubTimestamp":1732545131,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时32分,Nkarta, Inc.股票出现异动,股价快速上涨5.31%。截至发稿,该股报2.58美元/股,成交量3.0716万股,换手率0.04%,振幅1.63%。Nkarta, Inc.股票所在的生物技术行业中,整体涨幅为0.97%。Nkarta, Inc.公司简介:Nkarta Inc 是一家生物制药公司,致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223211a2548c6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223211a2548c6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4505","BK4139"],"gpt_icon":0},{"id":"2483382722","title":"Nkarta, Inc.盘中异动 股价大跌5.33%报2.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483382722","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483382722?lang=zh_cn&edition=full","pubTime":"2024-11-15 01:29","pubTimestamp":1731605397,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日01时29分,Nkarta, Inc.股票出现异动,股价快速跳水5.33%。截至发稿,该股报2.76美元/股,成交量46.7047万股,换手率0.66%,振幅5.15%。Nkarta, Inc.股票所在的生物技术行业中,整体跌幅为0.74%。Nkarta, Inc.公司简介:Nkarta Inc 是一家生物制药公司,致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115012958971a69d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115012958971a69d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4139","BK4505"],"gpt_icon":0},{"id":"2483583302","title":"Nkarta, Inc.2024财年第三财季实现净利润-28.34百万美元,同比减少10.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483583302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483583302?lang=zh_cn&edition=full","pubTime":"2024-11-14 00:00","pubTimestamp":1731513633,"startTime":"0","endTime":"0","summary":"11月14日,Nkarta, Inc.公布财报,公告显示公司2024财年第三财季净利润为-28.34百万美元,同比减少10.49%;其中营业收入为0.00美元,每股基本收益为-0.39美元。从资产负债表来看,Nkarta, Inc.总负债1.01亿美元,其中短期债务6.76百万美元,资产负债比为5.27,流动比率为0.13。机构评级:截至2024年11月14日,当前有7家机构对Nkarta, Inc.目标价做出预测,其中目标均价为16.86美元,其中最低目标价为11.00美元,最高目标价为25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114000115a2348677&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114000115a2348677&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX"],"gpt_icon":0},{"id":"2482738415","title":"Nkarta, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482738415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482738415?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:38","pubTimestamp":1731335934,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时38分,Nkarta, Inc.股票出现异动,股价快速上涨5.02%。截至发稿,该股报3.35美元/股,成交量3.543万股,换手率0.05%,振幅3.45%。Nkarta, Inc.股票所在的生物技术行业中,整体跌幅为0.26%。Nkarta, Inc.公司简介:Nkarta Inc 是一家生物制药公司,致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223855971a5b40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223855971a5b40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4139","BK4505"],"gpt_icon":0},{"id":"2481110174","title":"Nkarta, Inc.盘中异动 早盘快速跳水5.06%报3.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481110174","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481110174?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:33","pubTimestamp":1731076414,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时33分,Nkarta, Inc.股票出现异动,股价快速下跌5.06%。截至发稿,该股报3.10美元/股,成交量3.6701万股,换手率0.05%,振幅4.59%。Nkarta, Inc.股票所在的生物技术行业中,整体涨幅为0.36%。Nkarta, Inc.公司简介:Nkarta Inc 是一家生物制药公司,致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822333498e4178c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822333498e4178c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NKTX","BK4505"],"gpt_icon":0},{"id":"2481158588","title":"Nkarta, Inc.盘中异动 下午盘急速下跌5.07%报3.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481158588","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481158588?lang=zh_cn&edition=full","pubTime":"2024-11-08 03:21","pubTimestamp":1731007289,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日03时21分,Nkarta, Inc.股票出现波动,股价急速跳水5.07%。截至发稿,该股报3.18美元/股,成交量35.098万股,换手率0.50%,振幅5.67%。Nkarta, Inc.股票所在的生物技术行业中,整体涨幅为1.04%。Nkarta, Inc.公司简介:Nkarta Inc 是一家生物制药公司,致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108032129abaafdc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108032129abaafdc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","NKTX"],"gpt_icon":0},{"id":"2481617727","title":"Nkarta Inc 预计每股亏损 36 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481617727","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481617727?lang=zh_cn&edition=full","pubTime":"2024-11-06 13:26","pubTimestamp":1730870802,"startTime":"0","endTime":"0","summary":" * Nkarta Inc 预计在11月7日公布截至2024年9月30日的财报时,季度收入将没有变化(预计) * * LSEG 的分析师平均预计 Nkarta Inc 每股亏损 36 美分。* 目前,分析师对该公司股票的平均评级为 \"买入\",建议分类为 9 个 \"强烈买入 \"或 \"买入\",没有 \"持有\",也没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Nkarta Inc 的 12 个月目标价中位数为 17.00 美元,高于其上次收盘价 3.25 美元。11月6日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Nkarta Inc 预计每股亏损 36 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NKTX"],"gpt_icon":0},{"id":"2480587640","title":"Nkarta, Inc.盘中异动 早盘快速上涨5.02%报3.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480587640","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480587640?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:19","pubTimestamp":1730733599,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时19分,Nkarta, Inc.股票出现波动,股价快速上涨5.02%。截至发稿,该股报3.35美元/股,成交量12.1845万股,换手率0.17%,振幅5.80%。Nkarta, Inc.股票所在的生物技术行业中,整体涨幅为0.06%。Nkarta, Inc.公司简介:Nkarta Inc 是一家生物制药公司,致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104232000a2155f07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104232000a2155f07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NKTX","BK4505"],"gpt_icon":0},{"id":"2480088481","title":"Nkarta, Inc.盘中异动 早盘股价大涨5.19%报3.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480088481","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480088481?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:01","pubTimestamp":1730469717,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日22时01分,Nkarta, Inc.股票出现异动,股价快速上涨5.19%。截至发稿,该股报3.24美元/股,成交量6.4678万股,换手率0.09%,振幅4.22%。Nkarta, Inc.股票所在的生物技术行业中,整体涨幅为0.66%。Nkarta, Inc.公司简介:Nkarta Inc 是一家生物制药公司,致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101220157a2096efe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101220157a2096efe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NKTX","BK4505"],"gpt_icon":0},{"id":"2479033764","title":"Nkarta, Inc.盘中异动 急速下挫5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479033764","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479033764?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:58","pubTimestamp":1730383107,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时58分,Nkarta, Inc.股票出现波动,股价急速下跌5.07%。Nkarta, Inc.股票所在的生物技术行业中,整体跌幅为2.41%。其相关个股中,180 Life Sciences Corp C/Wts 07/11/2025、Psyence Biomedical Ltd C/Wts 25/01/2029、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大,Aditxt, Inc.、Evogene Ltd.、Palisade Bio, Inc.较为活跃,换手率分别为215.34%、214.82%、153.84%,振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Cingulate Inc C/Wts 10/12/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为45.05%、39.30%、28.17%。Nkarta, Inc.公司简介:Nkarta Inc 是一家生物制药公司,致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031215827a2023aca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031215827a2023aca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","NKTX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nkartatx.com","stockEarnings":[{"period":"1week","weight":-0.0393},{"period":"1month","weight":-0.1129},{"period":"3month","weight":-0.5777},{"period":"6month","weight":-0.6},{"period":"1year","weight":-0.4005},{"period":"ytd","weight":-0.6667}],"compareEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":-0.0071},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.0764},{"period":"1year","weight":0.2517},{"period":"ytd","weight":0.2331}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nkarta, Inc.于2015年7月在特拉华州成立。该公司是一家私人生物制药公司,致力于开发工程化的自然杀伤(NK)细胞来对抗癌症。该公司致力于利用NK细胞的天然强大功能来识别和杀死异常细胞,并募集适应性免疫效应子以产生特异性和持久性的反应。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.112423},{"month":2,"riseRate":0.5,"avgChangeRate":0.066988},{"month":3,"riseRate":0.25,"avgChangeRate":-0.082272},{"month":4,"riseRate":0.5,"avgChangeRate":0.150196},{"month":5,"riseRate":0.25,"avgChangeRate":-0.125785},{"month":6,"riseRate":0.25,"avgChangeRate":-0.12509},{"month":7,"riseRate":1,"avgChangeRate":0.058112},{"month":8,"riseRate":0.4,"avgChangeRate":-0.07656},{"month":9,"riseRate":0.2,"avgChangeRate":-0.069244},{"month":10,"riseRate":0.2,"avgChangeRate":-0.076206},{"month":11,"riseRate":0.6,"avgChangeRate":0.015473},{"month":12,"riseRate":0.4,"avgChangeRate":0.357198}],"exchange":"NASDAQ","name":"Nkarta","nameEN":"Nkarta"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nkarta(NKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nkarta(NKTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nkarta,NKTX,Nkarta股票,Nkarta股票老虎,Nkarta股票老虎国际,Nkarta行情,Nkarta股票行情,Nkarta股价,Nkarta股市,Nkarta股票价格,Nkarta股票交易,Nkarta股票购买,Nkarta股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nkarta(NKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nkarta(NKTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}